Scientific fraud: hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on apparent wrongdoing at the NIH laboratory of tumor cell biology and actions involving the Office of Scientific Integrity, March 6 and August 1, 1991, Volume 4
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
U.S. G.P.O., 1992 - Law - 260 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
DAmico Leo A Office of Special Investigations General Accounting
Other editions - View all
Ablashi accused action Adamson allegations April ASTA Pharma believe Bernadine Healy Bliley Chafin Chair Chairman Chasnov Cleveland Clinic concern conduct confidentiality conflict of interest consulting correct counsel D-Pen D-penicillamine D'Amico Degussa Dingell discussions DMSR documents draft report fact FAES funded Gallo Gallo's laboratory gentleman going grant application Hadley Hadley's Hallum Healy hearing Hyatt Imanishi-Kari inquiry panel Institutes of Health involved Laboratory of Tumor Lanman Lent Mason matter memo National Cancer Institute National Institutes Neg Neg NERIC O'Toole Office of Scientific OSIR Pan Data patients Pfizer Placenta Placenta extract potential question Raub recused regard Reponsif request Respondek responsibility Richards Panel Robert Gallo Rowland Salahuddin Sarin Schaefer Schulof Scientific Integrity scientific misconduct scientist second inquiry signature signed staff statement Storb subcommittee tell Thank tion told Tumor Cell Biology virus whistleblower